<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to the estimated binding affinity towards the protease, flavonoids have also shown promising ACE2 inhibitory activities [
 <xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>]. A study highlighted that 
 <bold>quercetin</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>d), 
 <bold>myricetin</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>b), 
 <bold>hesperetin</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>c), 
 <bold>tricetin</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>g), and 
 <bold>rutin</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>m) presented stable binding affinity against Spike-ACE2 protein [
 <xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]. It was suggested that these compounds formed interactions with Arg273, Thr371, His345, Pro346, Glu375, Glu402, and Tyr515 in the ACE2 binding site. With this in mind, it was hypothesized that these natural compounds could compete with the bind of SARS-CoV-2 to ACE2, thus preventing the virus entry into host cells [
 <xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>,
 <xref rid="B140-molecules-26-00632" ref-type="bibr">140</xref>].
</p>
